(Q51594652)
Statements
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. (English)
1 reference
Flier JS
1 reference
Morrow LA
1 reference
O'Brien MB
1 reference
Moller DE
1 reference
Moses AC
1 reference
1 July 1994
1 reference
79
1 reference
1
1 reference
205-210
1 reference